Periodontitis linked to HPV-positive head, neck tumors

June 20, 2012

Periodontitis linked to HPV-Positive head, neck tumors
For patients with head and neck squamous cell carcinoma there is an increased risk of human papillomavirus-positive tumors among those with a history of periodontitis, according to a study published online June 18 in the Archives of Otolaryngology -- Head & Neck Surgery.
(HealthDay) -- For patients with head and neck squamous cell carcinoma (HNSCC) there is an increased risk of human papillomavirus (HPV)-positive tumors among those with a history of periodontitis, according to a study published online June 18 in the Archives of Otolaryngology -- Head & Neck Surgery.

Mine Tezal, D.D.S., Ph.D., from the State University of New York at Buffalo, and colleagues evaluated dental records and tissue samples from 124 patients over the age of 21 years diagnosed with incident primary (SCC) of the oral cavity, oropharynx, and larynx between 1999 and 2007. Alveolar bone loss measured from panoramic radiographs was used to assess history, and the correlation between periodontitis and HPV status of HNSCC was evaluated.

The researchers found that the prevalence of HPV-positive HNSCC was 40.3 percent, with a higher proportion of oropharyngeal cancers HPV positive compared with oral cavity and laryngeal cancers (65.3 versus 29.0 and 20.5 percent, respectively). The odds of HPV-positive tumor status increased with each millimeter of alveolar bone loss (odds ratio [OR], 2.61), even after adjustment for age at diagnosis, sex, and smoking status. The odds of HPV-positive tumor status were greater among patients with oropharyngeal SCC (OR, 11.70), compared to those with oral cavity SCC (OR, 2.32; 95 percent confidence interval [CI], 0.65 to 8.27) and laryngeal SCC (OR, 3.89; 95 percent CI, 0.95 to 15.99).

"A history of chronic inflammatory disease in the oral cavity may be associated with tumor HPV status in patients with HNSCC," the authors write.

Explore further: Study examines chronic inflammation in oral cavity and HPV status of head and neck cancers

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study examines chronic inflammation in oral cavity and HPV status of head and neck cancers

June 18, 2012
Among patients with head and neck squamous cell carcinomas, a history of chronic inflammation in the mouth (periodontitis, i.e. gum disease) may be associated with an increased risk of tumors positive for human papillomavirus ...

Gender, insurance type tied to HPV infection in laryngeal cancer patients

September 14, 2011
The human papillomavirus (HPV) is more likely to be found in tumors of laryngeal cancer patients who are male and those with private health insurance, according to a new study from researchers at Henry Ford Hospital.

Oral HPV infection, HPV-related cancers more common in men

January 26, 2012
Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer ...

Recommended for you

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

Traditional chemotherapy superior to new alternative for oropharyngeal cancers

November 16, 2018
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...

Repurposing FDA-approved drugs can help fight back breast cancer

November 16, 2018
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in ...

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.